✦ LIBER ✦

Drug–Drug Interactions with Sodium-Glucose Cotransporters Type 2 (SGLT2) Inhibitors, New Oral Glucose-Lowering Agents for the Management of Type 2 Diabetes Mellitus

✍ Scribed by Scheen, AndrÃ© J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dapagliflozin: A Novel Sodium-Glucose Co

✍ Niren K. Shah; Wasim E. Deeb; Rushab Choksi; Benjamin J. Epstein 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Canagliflozin, an inhibitor of sodium–gl

✍ Lamos, Elizabeth M; Younk, Lisa M; Davis, Stephen N 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 473 KB

Novel l-Xylose Derivatives as Selective

✍ Goodwin, Nicole C.; Mabon, Ross; Harrison, Bryce A.; Shadoan, Melanie K.; Almste 📂 Article 📅 2009 🏛 American Chemical Society 🌐 English ⚖ 762 KB

The Clinical Efficacy and Safety of Sodi

✍ Riser Taylor, Shawn; Harris, Kira B. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Discovery of Dapagliflozin: A Potent, Se

✍ Meng, Wei; Ellsworth, Bruce A.; Nirschl, Alexandra A.; McCann, Peggy J.; Patel, 📂 Article 📅 2008 🏛 American Chemical Society 🌐 English ⚖ 203 KB

The potential of sodium glucose cotransp

✍ Basile, Jan N. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 287 KB